Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Journal of Pediatric Hematology/Oncology
|
September 14, 2017
Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma
Sarah B Whittle, Jyotinder N Punia, Dolores López-Terrada, et al.
BMC Bioinformatics
|
April 29, 2016
ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data
Navin Rustagi, Oliver A Hampton, Jie Li, et al.
Plos One
|
December 30, 2020
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden
McKayla J Riggs, Nan Lin, Chi Wang, et al.
BMC Genomics
|
October 7, 2017
SVachra: a tool to identify genomic structural variation in mate pair sequencing data containing inward and outward facing reads
Oliver A Hampton, Adam C English, Mark Wang, et al.
Genome Research
|
December 6, 2008
A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome
Oliver A Hampton, Petra Den Hollander, Christopher A Miller, et al.
Cancer Genetics
|
October 4, 2011
Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines
Oliver A Hampton, Maxim Koriabine, Christopher A Miller, et al.
Frontiers in Cardiovascular Medicine
|
July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
Marwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Pediatric Blood & Cancer
|
September 30, 2014
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673
Malcolm A Smith, Oliver A Hampton, C Patrick Reynolds, et al.
Blood
|
October 13, 2016
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Rikhia Chakraborty, Thomas M Burke, Oliver A Hampton, et al.
Hepatology (Baltimore, Md.)
|
October 25, 2016
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Pavel Sumazin, Yidong Chen, Lisa R Treviño, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Journal of Pediatric Hematology/Oncology
|
September 14, 2017
Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma
Sarah B Whittle, Jyotinder N Punia, Dolores López-Terrada, et al.
BMC Bioinformatics
|
April 29, 2016
ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data
Navin Rustagi, Oliver A Hampton, Jie Li, et al.
Plos One
|
December 30, 2020
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden
McKayla J Riggs, Nan Lin, Chi Wang, et al.
BMC Genomics
|
October 7, 2017
SVachra: a tool to identify genomic structural variation in mate pair sequencing data containing inward and outward facing reads
Oliver A Hampton, Adam C English, Mark Wang, et al.
Genome Research
|
December 6, 2008
A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome
Oliver A Hampton, Petra Den Hollander, Christopher A Miller, et al.
Cancer Genetics
|
October 4, 2011
Long-range massively parallel mate pair sequencing detects distinct mutations and similar patterns of structural mutability in two breast cancer cell lines
Oliver A Hampton, Maxim Koriabine, Christopher A Miller, et al.
Frontiers in Cardiovascular Medicine
|
July 6, 2023
Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma
Marwa Tantawy, Guang Yang, Raghunandan Reddy Algubelli, et al.
Pediatric Blood & Cancer
|
September 30, 2014
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673
Malcolm A Smith, Oliver A Hampton, C Patrick Reynolds, et al.
Blood
|
October 13, 2016
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Rikhia Chakraborty, Thomas M Burke, Oliver A Hampton, et al.
Hepatology (Baltimore, Md.)
|
October 25, 2016
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
Pavel Sumazin, Yidong Chen, Lisa R Treviño, et al.
Page
of 3